WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001082954) CERULOPLASMIN AND USES THEREOF IN NEURODEGENERATIVE RELATED CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/082954    International Application No.:    PCT/CA2001/000618
Publication Date: 08.11.2001 International Filing Date: 02.05.2001
Chapter 2 Demand Filed:    30.11.2001    
IPC:
A61K 38/44 (2006.01), A61K 38/57 (2006.01), A61K 47/48 (2006.01)
Applicants: UNIVERSITE DU QUEBEC A MONTREAL [CA/CA]; Succursale Centre-Ville, Case Postale 8888, Montréal, Québec H3C 3P8 (CA) (For All Designated States Except US).
PAQUIN, Joanne [CA/CA]; (CA) (For US Only).
MALTAIS, Domynick [CA/CA]; (CA) (For US Only).
MATEESCU, Mircea, Alexandru [CA/CA]; (CA) (For US Only)
Inventors: PAQUIN, Joanne; (CA).
MALTAIS, Domynick; (CA).
MATEESCU, Mircea, Alexandru; (CA)
Agent: ROBIC; 55 St-Jacques, Montréal, Québec H2Y 3X2 (CA)
Priority Data:
2,307,475 03.05.2000 CA
Title (EN) CERULOPLASMIN AND USES THEREOF IN NEURODEGENERATIVE RELATED CONDITIONS
(FR) CERULOPLASMINE ET SES UTILISATIONS DANS LE CADRE DE TROUBLES LIES A LA NEURODEGENERESCENCE
Abstract: front page image
(EN)The present invention relates to the use of ceruloplasmin (and/or derivatives thereof) for treating neurodegenerative related conditions. More particularly, the present invention pertains to the use of ceruloplasmin in pharmaceutical neurotrophic compositions, to its use as a carrier for delivering therapeutic agent(s) to tissues of the nervous systems and to its use in methods for culturing neuronal cells in vitro. The present invention is useful for maintaining or stimulating the regeneration of neuronal cells, particularly for the treatment of injuries to the brain, the spinal cord and other central nervous system tissues.
(FR)La présente invention concerne l'utilisation de ceruloplasmine (et/ou de ses dérivés) pour traiter des troubles liés à la neurodégénérescence. Plus particulièrement, la présente invention concerne l'utilisation de ceruloplasmine dans des compositions pharmaceutiques neurotrophiques, son utilisation en tant que porteur servant à administrer un/des agent(s) thérapeutique(s) à des tissus du système nerveux, et son utilisation dans des procédés servant à réaliser la culture de cellules neuronales in vitro. La présente invention peut être utilisée pour conserver ou stimuler la régénération de cellules neuronales, en particulier pour le traitement de blessures touchant le cerveau, la moelle épinière, et d'autres tissus du système nerveux central.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)